#United States #Genomics #Menlo Park #MyOme #Novi Health

MyOme and Novi Health Collaborate to Enhance Employee Health with Genome Testing

In a groundbreaking initiative, MyOme, a clinical leader in genomic analysis, has forged a strategic partnership with Novi Health aimed at transforming workplace healthcare. This collaboration signifies a major advancement in preventive health measures, providing employees with direct access to whole genome sequencing (WGS) and invaluable genetic counseling services as part of their workplace health benefits.

Empowering Employees Through Genomics

Novi Health's focus on personalized and preventative healthcare aligns seamlessly with MyOme's expertise in whole genomic analysis. By utilizing MyOme's advanced WGS technology, companies can offer their staff comprehensive insights into genetic risks associated with both common and rare hereditary conditions. Employees alongside their families will benefit greatly from robust preventative care, which is increasingly vital in today’s health landscape.

The heart of this program lies in its ability to identify potential health risks that could lead to serious health conditions like cancer and heart diseases. MyOme’s reports encompass a wide variety of genetic factors, including single-gene risks and polygenic risk scores (PRS) for conditions such as breast cancer, coronary artery disease, and type II diabetes.

Technology and Accessibility

One key advantage of this partnership is the simplicity of the testing process. A single cheek swab can unlock a lifetime of valuable health insights without the need for further samples as reports develop with new scientific findings. This scalability not only benefits individual employees but also plays a pivotal role in establishing a culture of health consciousness within organizations.

Comprehensive Support and Education

Alongside genetic testing, the collaboration ensures participants receive expert support throughout their health journey. Each participant will gain access to educational resources, personalized recommendations, and direct connections to certified genetic counselors. These counselors help individuals interpret their genetic information and formulate effective prevention strategies, making this a holistic approach to healthcare.

Dr. Jeffrey Weitzel, Chief Medical Officer at Novi Health, highlights the potential impact of this initiative: "More than 50% of cancers and up to 80% of cardiac diseases are preventable. By integrating genomics into employer health programs, we provide participants with knowledge that can save lives and significantly improve outcomes." This statement underscores the pivotal role early detection and intervention can play in enhancing public health.

A Commitment to Proactive Healthcare

As this program becomes available to participating employees, it represents a shift towards more proactive healthcare management and emphasizes the importance of genetic insights in everyday health decisions. Both companies aim to expand their reach, continuously seeking to partner with more organizations to bring these vital health solutions to a broader audience.

"Our mission is to make clinical-grade genomic insights accessible and actionable," says Dr. Yasser Ads, Chief Business Officer at MyOme. Together, MyOme and Novi Health are dedicated to providing employees with the knowledge and tools necessary to make informed health decisions, ultimately leading to reduced healthcare costs and improved patient outcomes.

Conclusion

In summary, the collaboration between MyOme and Novi Health marks a significant step in the evolution of employee health programs. By leveraging cutting-edge genomic technology and providing personalized support, this initiative not only empowers individuals to take control of their health but also promises to reshape the future landscape of workplace wellness.